Evidence map›Paper›PMID 21575704›Full record

ArticleMicrobial pathogenesis2011

Tn5AraOut mutagenesis for the identification of Yersinia pestis genes involved in resistance towards cationic antimicrobial peptides.

Jitao Guo, Manoj K M Nair, Estela M Galván, Shu-Lin Liu, Dieter M Schifferli

Open access · bronzeAbstract read
In one paragraph

Article in Microbial pathogenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Lipopolysaccharide of theBiomolecules · 2021
    Review
  3. ACS infectious diseases · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Iron homeostasis in theAdvances in botanical research · 2013
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jitao GuoDepartment of Microbiology, Peking University Health Science Center, Beijing 100191, China. jitaoguo@bjmu.edu.cn
Manoj K M Nair
Estela M Galván
Shu-Lin Liu
Dieter M Schifferli
University of Pennsylvania · USPeking University · CN

Funding

The Psa fimbriae of Yersinia pestis, an adhesin with protective immunogenic propeR21AI076695 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SCHIFFERLI, DIETER M. · 2009 to 2010
$447k
NIAID NIH HHS R21 AI076695PHS HHS RAI076695
6 · The paper itself

Abstract

Bacterial pathogens display a variety of protection mechanisms against the inhibitory and lethal effects of host cationic antimicrobial peptides (CAMPs). To identify Yersinia pestis genes involved in CAMP resistance, libraries of DSY101 (KIM6 caf1 pla psa) minitransposon Tn5AraOut mutants were selected at 37°C for resistance to the model CAMPs polymyxin B or protamine. This approach targeted genes that needed to be repressed (null mutations) or induced (upstream P(BAD) insertions) for the detection of CAMP resistance, and predictably for improved pathogen fitness in mammalian hosts. Ten mutants demonstrated increased resistance to polymyxin B or protamine, with the mapped mutations pointing towards genes suspected to participate in modifying membrane components, genes encoding transport proteins or enzymes, or the regulator of a ferrous iron uptake system (feoC). Not all the mutants were resistant to both CAMPs used for selection. None of the polymyxin B- and only some protamine-resistant mutants, including the feoC mutant, showed increased resistance to rat bronchoalveolar lavage fluid (rBALF) known to contain cathelicidin and β-defensin 1. Thus, findings on bacterial resistance to polymyxin B or protamine don't always apply to CAMPs of the mammalian innate immune system, such as the ones in rBALF.

Indexed as

Drug Resistance, BacterialAnti-Infective AgentsAntimicrobial Cationic PeptidesDNA Transposable ElementsMutagenesis, InsertionalPolymyxin BProtaminesYersinia pestisAnti-Infective AgentsAntimicrobial Cationic PeptidesDNA Transposable ElementsPolymyxin BProtamines

Identifiers

PMID21575704
PMCPMC3120914
OpenAlexW2017559075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.